You are here

FTC

In Jazz case, FTC urges court to delist patent on blockbuster Xyrem

Fierce Pharma

Mon, 11/14/22 - 10:55 am

FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition

FTC

Sun, 11/13/22 - 06:56 pm

Jazz Pharmaceuticals

EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case

Endpoints

Tue, 09/6/22 - 10:36 am

Illumina defeats F.T.C. in major antitrust case

NY Times, NY

Thu, 09/1/22 - 07:46 pm

FTC Unanimously Agrees to Keep Close Eye on PBMs, Higher Drug Costs

BioSpace

Mon, 06/20/22 - 10:27 am

Pharma under the microscope as FTC considers new ways to review acquisitions

BioPharma Dive

Fri, 06/17/22 - 10:38 am

FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'

Endpoints

Fri, 06/17/22 - 10:04 am

Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report

Fierce Pharma

Tue, 06/14/22 - 08:57 pm

Bristol Myers Squibb

FTC launches probe into pharmacy benefit management sector

Pharmaforum

Wed, 06/8/22 - 10:11 am

Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill

Endpoints

Thu, 05/26/22 - 10:48 pm

Medtronic Hits an FTC Roadblock in Intersect ENT Deal

Medical Devices and Diagnostics Industry

Wed, 05/11/22 - 11:02 pm

FTC deadlocks on vote to launch study into PBM practices

BioPharma Dive

Fri, 02/18/22 - 10:33 am

FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies

Endpoints

Wed, 02/16/22 - 11:16 pm

Biogen says U.S. FTC, SEC probing Alzheimer's disease drug

Reuters

Mon, 02/7/22 - 11:26 pm

Alzheimer's disease

Merck Delays Acceleron Deal Amidst Continuing Stakeholder Criticism

BioSpace

Mon, 11/1/21 - 11:19 pm

Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes

Endpoints

Fri, 09/10/21 - 10:58 am

Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028

Fierce Pharma

Tue, 09/7/21 - 10:43 pm

Bristol Myers Squibb

Sanofi refiles $3.2B Translate Bio buyout with FTC to allow more time for review

Fierce Pharma

Tue, 08/31/21 - 10:06 pm

Illumina purchases Grail without clearance from FTC or European Union

Stat

Wed, 08/18/21 - 11:32 pm

As AbbVie and Soliton shake hands on a $550M merger, the FTC says 'not so fast'

Endpoints

Wed, 08/11/21 - 12:14 pm

Pages